3B Blackbio Dx Limited (BOM:532067)
India · Delayed Price · Currency is INR 1,463.50
+54.10 (3.84%)
At close: Sep 25, 2026
3B Blackbio Dx Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 1,532 | 1,419 | 964.69 | 744.13 | 620.68 | 875.5 |
Revenue Growth | 54.30% | 47.11% | 29.64% | 19.89% | -29.10% | -61.87% |
Gross Profit Gross Profit Growth | 1,153 | 1,050 | 704.06 | 522.75 | 441.52 | 557.2 |
Operating Income Operating Income Growth | 490.11 | 630.63 | 493.66 | 324.04 | 289.52 | 433.3 |
Net Income Net Income Growth | 555.29 | 599.3 | 476.91 | 321.01 | 259.37 | 322 |
Earnings Per Share EPS Growth | 65.19 | 69.94 | 55.66 | 37.46 | 30.28 | 42.98 |
EPS Growth | 13.94% | 25.66% | 48.57% | 23.74% | -29.55% | -71.72% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Agrochemicals Agrochemicals Growth | 99.59 | 108 | 121.86 | 136.85 | 119.98 | 155.23 |
Diagnostic Kits Diagnostic Kits Growth | 1,432 | 1,311 | 842.83 | 608.52 | 505.16 | 668.28 |
Total Total Growth | 1,532 | 1,419 | 964.69 | 745.37 | 625.14 | 823.51 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 1,006 | 1,006 | 688.32 | 136.19 | 60.02 | 288.92 |
Total Debt Total Debt Growth | 31.07 | 47.73 | 3.07 | 7.88 | 20.29 | 25.3 |
Net Cash (Debt) Net Cash Growth | 975.13 | 958.46 | 685.25 | 128.31 | 39.73 | 263.62 |
Net Cash Growth | 701.52% | 39.87% | 434.07% | 222.96% | -84.93% | -20.30% |
Net Cash Per Share Net Cash Per Share Growth | 114.48 | 111.86 | 79.97 | 14.97 | 4.64 | 35.19 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 524.76 | 433.57 | 269.51 | 202.84 | 373.26 |
Capital Expenditures CapEx Growth | - | -255.1 | -9.04 | -5.08 | -20.25 | -22.63 |
Free Cash Flow Free Cash Flow Growth | - | 269.66 | 424.53 | 264.43 | 182.6 | 350.63 |
Free Cash Flow Growth | - | -36.48% | 60.54% | 44.82% | -47.92% | -63.42% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 75.29% | 74.01% | 72.98% | 70.25% | 71.14% | 63.64% |
Operating Margin | 32.00% | 44.44% | 51.17% | 43.55% | 46.65% | 49.49% |
Pretax Margin | 48.52% | 54.24% | 66.34% | 59.58% | 56.89% | 49.37% |
Profit Margin | 36.25% | 42.23% | 49.44% | 43.14% | 41.79% | 36.78% |
FCF Margin | - | 19.00% | 44.01% | 35.53% | 29.42% | 40.05% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 25, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 5.000 | 5.000 | 4.000 | 3.000 | 2.500 | 2.500 |
Dividend Per Share Growth | 25.00% | 25.00% | 33.33% | 20.00% | 0% | 150.00% |
Dividend Yield | 0.34% | 0.45% | 0.25% | 0.39% | 0.61% | 0.75% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 25, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 21.62 | 16.10 | 29.05 | 20.58 | 12.03 | 7.96 |
P/FCF Ratio | 44.86 | 35.78 | 32.63 | 24.98 | 17.09 | 7.31 |
PS Ratio | 7.90 | 6.80 | 14.36 | 8.88 | 5.03 | 2.93 |